HR 796 · 119th CongressIn Committeecongress.gov ↗

Second Chance for Moms Act

What this bill does

AI plain-language summary

This bill requires new labels on the drug mifepristone to include information about the hormone progesterone. The bill also creates a telephone hotline related to this labeling requirement. Mifepristone is a drug approved to end pregnancies through 10 weeks when used with another drug called misoprostol, which is often called medication abortion or the abortion pill.

Introduced

January 28, 2025

Policy Area

Health

Your Vote

Discussion (0)

Explain what is at stake in this bill.

Sign in to join the discussion.

No comments yet. Be the first.